Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Ischemic Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 172 articles:
HTML format



Single Articles


    May 2020
  1. DE ROSA S, Spaccarotella C, Basso C, Calabro MP, et al
    Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2020 May 15. pii: 5837572. doi: 10.1093.
    PubMed     Abstract available


  2. CHIEFFO A, Stefanini GG, Price S, Barbato E, et al
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
    Eur Heart J. 2020;41:1839-1851.
    PubMed     Abstract available


  3. METZLER B, Siostrzonek P, Binder RK, Bauer A, et al
    Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.
    Eur Heart J. 2020;41:1852-1853.
    PubMed    


  4. CAMPO G, Rapezzi C, Tavazzi L, Ferrari R, et al
    Priorities for Cath labs in the COVID-19 tsunami.
    Eur Heart J. 2020;41:1784-1785.
    PubMed    


  5. SHAH R
    Accuracy of fractional flow reserve during acute myocardial infarction.
    Eur Heart J. 2020 May 8. pii: 5834910. doi: 10.1093.
    PubMed    


  6. UEKI Y, Otsuka T, Windecker S, Raber L, et al
    ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome.
    Eur Heart J. 2020 May 6. pii: 5831090. doi: 10.1093.
    PubMed    


  7. GAUDINO M, Freemantle N, Farkouh ME
    The conundrum of the treatment for left main coronary disease.
    Eur Heart J. 2020 May 5. pii: 5830808. doi: 10.1093.
    PubMed    


    April 2020
  8. DREXLER M, Elsner C, Gabelmann V, Gori T, et al
    Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away.
    Eur Heart J. 2020 Apr 29. pii: 5826159. doi: 10.1093.
    PubMed    


  9. HAN Y
    A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience.
    Eur Heart J. 2020 Apr 27. pii: 5825637. doi: 10.1093.
    PubMed    


  10. ZULLO A, Lorenzetti R, Hassan C
    Is Escherichia coli involved in the myocardial infarction?
    Eur Heart J. 2020 Apr 16. pii: 5821041. doi: 10.1093.
    PubMed    


  11. VIOLI F, Nocella C, Carnevale R
    Gut microbiota and myocardial infarction.
    Eur Heart J. 2020 Apr 16. pii: 5821053. doi: 10.1093.
    PubMed    


  12. CHATTERJEE NA, Tikkanen JT, Panicker GK, Narula D, et al
    Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease.
    Eur Heart J. 2020 Apr 7. pii: 5817075. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  13. JING ZC, Zhu HD, Yan XW, Chai WZ, et al
    Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak.
    Eur Heart J. 2020 Mar 31. pii: 5813956. doi: 10.1093.
    PubMed    


  14. STONE GW, Ben-Yehuda O, Sabik JF, Kappetein AP, et al
    Considerations for an optimal definition of procedural myocardial infarction.
    Eur Heart J. 2020 Mar 30. pii: 5813684. doi: 10.1093.
    PubMed    


  15. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  16. HARTIKAINEN TS, Sorensen NA, Haller PM, Gossling A, et al
    Clinical application of the 4th Universal Definition of Myocardial Infarction.
    Eur Heart J. 2020 Feb 20. pii: 5741381. doi: 10.1093.
    PubMed     Abstract available


  17. ALLAHYARI A, Jernberg T, Hagstrom E, Leosdottir M, et al
    Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.
    Eur Heart J. 2020 Feb 18. pii: 5739477. doi: 10.1093.
    PubMed     Abstract available


  18. RYMER JA, Granger CB
    Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?
    Eur Heart J. 2020 Feb 7. pii: 5729984. doi: 10.1093.
    PubMed    


  19. RAMASAMY A, Bajaj R, Choudry FA, Pugliese F, et al
    Intravascular ultrasound-guided management of ST-elevation myocardial infarction in a patient with lung cancer and myocardial metastasis.
    Eur Heart J. 2020 Feb 7. pii: 5729982. doi: 10.1093.
    PubMed    


    January 2020
  20. CARNEVALE R, Sciarretta S, Valenti V, di Nonno F, et al
    Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.
    Eur Heart J. 2020 Jan 3. pii: 5695525. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  21. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
    Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
    PubMed     Abstract available


  22. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    PubMed    


  23. WELSH RC
    Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
    Eur Heart J. 2019 Dec 23. pii: 5686009. doi: 10.1093.
    PubMed    


  24. ROEVER L, Tse G, Versaci F, Biondi-Zoccai G, et al
    Admission glucagon-like peptide-1 levels in acute myocardial infarction: is this a new biomarker of cardiovascular risk?
    Eur Heart J. 2019 Dec 13. pii: 5675546. doi: 10.1093.
    PubMed    


  25. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    PubMed     Abstract available


  26. FURTADO RHM, Nicolau JC, Magnani G, Im K, et al
    Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2019 Dec 7. pii: 5663567. doi: 10.1093.
    PubMed     Abstract available


  27. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  28. RIMBERT A, Dalila N, Wolters JC, Huijkman N, et al
    A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.
    Eur Heart J. 2019 Oct 19. pii: 5599853. doi: 10.1093.
    PubMed     Abstract available


  29. KAHLES F, Ruckbeil MV, Mertens RW, Foldenauer AC, et al
    Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.
    Eur Heart J. 2019 Oct 16. pii: 5588525. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  30. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
    Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
    Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
    PubMed     Abstract available


  31. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
    16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
    PubMed     Abstract available


  32. MUKHERJEE D
    Tailoring strategies to optimize ischaemic benefit vs. bleeding risk in individuals post-myocardial infarction.
    Eur Heart J. 2019 Sep 1. pii: 5555736. doi: 10.1093.
    PubMed    


  33. SIMONSSON M, Wallentin L, Alfredsson J, Erlinge D, et al
    Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2019 Sep 1. pii: 5554428. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  34. CREA F, Montone RA, Niccoli G
    Myocardial infarction with non-obstructive coronary atherosclerosis: dealing with pears and apples.
    Eur Heart J. 2019 Aug 3. pii: 5543490. doi: 10.1093.
    PubMed    


    July 2019
  35. ODER D, Topp MS, Nordbeck P
    Coronary B-cell lymphoma infiltration causing myocardial infarction.
    Eur Heart J. 2019 Jul 31. pii: 5542062. doi: 10.1093.
    PubMed    


  36. FRANGOGIANNIS NG
    S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
    Eur Heart J. 2019 Jul 23. pii: 5537337. doi: 10.1093.
    PubMed    


  37. MARINKOVIC G, Grauen Larsen H, Yndigegn T, Szabo IA, et al
    Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
    Eur Heart J. 2019 Jul 10. pii: 5530698. doi: 10.1093.
    PubMed     Abstract available


  38. THIELE H, Ohman EM, de Waha-Thiele S, Zeymer U, et al
    Management of cardiogenic shock complicating myocardial infarction: an update 2019.
    Eur Heart J. 2019 Jul 4. pii: 5528526. doi: 10.1093.
    PubMed     Abstract available


    June 2019

  39. Corrigendum to: Ephemeral Coronary Heart Disease.
    Eur Heart J. 2019 Jun 29. pii: 5530690. doi: 10.1093.
    PubMed    


  40. THYGESEN K, Jaffe AS
    Should myocardial infarction type 2 be regarded as two separate entities?
    Eur Heart J. 2019 Jun 26. pii: 5523696. doi: 10.1093.
    PubMed    


  41. MESSERLI FH
    Ephemeral Coronary Heart Disease.
    Eur Heart J. 2019;40:1906-1908.
    PubMed    


  42. DREYER RP, Tavella R, Curtis JP, Wang Y, et al
    Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
    Eur Heart J. 2019 Jun 21. pii: 5521361. doi: 10.1093.
    PubMed     Abstract available


  43. WHITE HD
    Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective.
    Eur Heart J. 2019;40:e4-e7.
    PubMed    


  44. ZENG L, Ntalla I, Kessler T, Kastrati A, et al
    Genetically modulated educational attainment and coronary disease risk.
    Eur Heart J. 2019 Jun 6. pii: 5512096. doi: 10.1093.
    PubMed     Abstract available


  45. LI Z, Solomonidis EG, Meloni M, Taylor RS, et al
    Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510786. doi: 10.1093.
    PubMed     Abstract available


  46. ROHDE D, Nahrendorf M
    Clonal and diverse: revisiting cardiac endothelial cells after myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510784. doi: 10.1093.
    PubMed    


    May 2019
  47. LEMKES JS, Janssens GN, van Royen N
    ST-resolution and spontaneous reperfusion in patients with transient ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 May 29. pii: 5506052. doi: 10.1093.
    PubMed    


  48. WHITE HD, Steg PG, Szarek M, Bhatt DL, et al
    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
    Eur Heart J. 2019 May 23. pii: 5497814. doi: 10.1093.
    PubMed     Abstract available


  49. NISHI T, Funabashi N, Fujimoto Y, Kobayashi Y, et al
    Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly.
    Eur Heart J. 2019 May 3. pii: 5485104. doi: 10.1093.
    PubMed    


  50. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  51. HU C, Tkebuchava T, Hu D
    Managing acute myocardial infarction in China.
    Eur Heart J. 2019;40:1179-1181.
    PubMed    


  52. MEHRAN R, Kalkman DN, Angiolillo DJ
    Atrial fibrillation, with ACS and PCI: walking a tightrope.
    Eur Heart J. 2019 Apr 8. pii: 5431179. doi: 10.1093.
    PubMed    


    March 2019
  53. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
    Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
    PubMed     Abstract available


  54. HERRING N, Tapoulal N, Kalla M, Ye X, et al
    Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
    Eur Heart J. 2019 Mar 11. pii: 5374846. doi: 10.1093.
    PubMed     Abstract available


  55. CHEN K, Breitner S, Wolf K, Hampel R, et al
    Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987-2014.
    Eur Heart J. 2019 Mar 11. pii: 5374842. doi: 10.1093.
    PubMed     Abstract available


  56. YOSHIDA R, Takagi K, Morita Y, Morishima I, et al
    Incidentally discovered left ventricular pseudoaneurysm after silent myocardial infarction occurred in a young woman with peritoneal dialysis.
    Eur Heart J. 2019 Mar 11. pii: 5374728. doi: 10.1093.
    PubMed    


  57. SEHESTED TSG, Carlson N, Hansen PW, Gerds TA, et al
    Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
    Eur Heart J. 2019 Mar 9. pii: 5372329. doi: 10.1093.
    PubMed     Abstract available


  58. REDFORS B, Dworeck C, Haraldsson I, Angeras O, et al
    Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Eur Heart J. 2019 Mar 9. pii: 5372330. doi: 10.1093.
    PubMed     Abstract available


  59. RABER L, Yamaji K, Kelbaek H, Engstrom T, et al
    Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial inf
    Eur Heart J. 2019 Mar 9. pii: 5372331. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  60. HECHT HS, Shaw L, Chandrashekhar YS, Bax JJ, et al
    Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate.
    Eur Heart J. 2019 Feb 27. pii: 5366197. doi: 10.1093.
    PubMed     Abstract available


  61. WITASSEK F, Radovanovic D, Erne P, Puhan M, et al
    Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals.
    Eur Heart J. 2019;40:410.
    PubMed    


    January 2019
  62. CHEN S, Stone GW
    Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
    Eur Heart J. 2019 Jan 30. pii: 5304404. doi: 10.1093.
    PubMed    


  63. WU J, Hall M, Dondo TB, Wilkinson C, et al
    Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.
    Eur Heart J. 2019 Jan 29. pii: 5301310. doi: 10.1093.
    PubMed     Abstract available


  64. VACCARINO V, Badimon L, Bremner JD, Cenko E, et al
    Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.
    Eur Heart J. 2019 Jan 28. pii: 5303703. doi: 10.1093.
    PubMed    


  65. THYGESEN K
    'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018.
    Eur Heart J. 2019;40:226.
    PubMed    


    December 2018
  66. LUSCHER TF
    Personalized approaches to heart failure: age, acute presentation, and comorbidities.
    Eur Heart J. 2018;39:4223-4226.
    PubMed    


  67. RESOR CD, Bhatt DL
    Bioresorbable vascular scaffolds in acute myocardial infarction: non-inferior or not enough data?
    Eur Heart J. 2018 Dec 18. pii: 5251899. doi: 10.1093.
    PubMed    


  68. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  69. SHARMA S, Malhotra A
    Exercise testing and coronary disease: pushing fitness to higher peaks.
    Eur Heart J. 2018 Nov 29. pii: 5193507. doi: 10.1093.
    PubMed    


  70. LETNES JM, Dalen H, Vesterbekkmo EK, Wisloff U, et al
    Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study.
    Eur Heart J. 2018 Nov 29. pii: 5193503. doi: 10.1093.
    PubMed     Abstract available


  71. XIN Y, Chen X, Hu W
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Nov 28. pii: 5212709. doi: 10.1093.
    PubMed    


  72. POLIMENI A, Spaccarotella C, Mongiardo A, Indolfi C, et al
    Myocardial infarction after dog bite.
    Eur Heart J. 2018 Nov 28. pii: 5212711. doi: 10.1093.
    PubMed    


  73. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    PubMed    


  74. THYGESEN K
    What's new in the Fourth Universal Definition of Myocardial infarction?
    Eur Heart J. 2018;39:3757-3758.
    PubMed    


  75. ELNABAWI YA, Dey AK, Mehta NN
    Emerging Applications of Coronary CT Angiography in Coronary Heart Disease: Getting Better with Time.
    Eur Heart J. 2018;39:3682-3684.
    PubMed    


    October 2018
  76. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Abstract available


  77. LEMKES JS, Janssens GN, van der Hoeven NW, van de Ven PM, et al
    Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
    Eur Heart J. 2018 Oct 26. pii: 5145843. doi: 10.1093.
    PubMed     Abstract available


  78. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
    Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
    PubMed     Abstract available


  79. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
    A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
    Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
    PubMed     Abstract available


  80. WALLENTIN L
    Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
    Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
    PubMed    


    September 2018
  81. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Abstract available


  82. STONE GW, Genereux P, Harrington RA, White HD, et al
    Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
    Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
    PubMed     Abstract available


  83. HALL M, Bebb OJ, Dondo TB, Yan AT, et al
    Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.
    Eur Heart J. 2018 Sep 7. pii: 5092654. doi: 10.1093.
    PubMed     Abstract available


  84. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality.
    Eur Heart J. 2018 Sep 6. pii: 5091846. doi: 10.1093.
    PubMed    


  85. NESTELBERGER T, Boeddinghaus J, Mueller C
    Type 2 myocardial infarction.
    Eur Heart J. 2018 Sep 6. pii: 5091844. doi: 10.1093.
    PubMed    


    August 2018
  86. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
    Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
    Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
    PubMed     Abstract available


  87. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth universal definition of myocardial infarction (2018).
    Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
    PubMed    


  88. SHIMONO H, Kajiya T, Atsuchi Y, Atsuchi N, et al
    Giant left ventricular pseudo-aneurysm after posterior myocardial infarction.
    Eur Heart J. 2018 Aug 21. pii: 5077320. doi: 10.1093.
    PubMed    


  89. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
    Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  90. VARENNE O, Sinnaeve PR
    De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
    PubMed    


  91. LUSCHER TF
    Performance of modern stents in stable and acute coronary disease.
    Eur Heart J. 2018;39:2435-2438.
    PubMed    


    June 2018
  92. SAITO S, Krucoff MW, Nakamura S, Mehran R, et al
    Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-elu
    Eur Heart J. 2018 Jun 21. pii: 5042208. doi: 10.1093.
    PubMed     Abstract available


  93. HOFMANN R, Witt N, Lagerqvist B, Jernberg T, et al
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Jun 14. pii: 5037999. doi: 10.1093.
    PubMed     Abstract available


  94. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Eur Heart J. 2018;39:2192-2207.
    PubMed     Abstract available


    May 2018
  95. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
    Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
    PubMed    


  96. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed    


  97. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Abstract available


  98. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
    Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
    Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  99. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  100. WALDMANN V, Bougouin W, Karam N, Dumas F, et al
    Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
    Eur Heart J. 2018 Mar 16. pii: 4939309. doi: 10.1093.
    PubMed     Abstract available


  101. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Abstract available


  102. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  103. THYGESEN K, Jaffe AS
    The prognostic impact of periprocedural myocardial infarction and injury.
    Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
    PubMed    


  104. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
    PubMed     Abstract available



  105. euro6.5 million award to study impact of ECMO on myocardial infarction patients.
    Eur Heart J. 2018;39:649.
    PubMed    


  106. WIJNS W, Naber CK
    Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
    Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
    PubMed    


  107. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  108. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    PubMed     Abstract available


  109. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Abstract available


  110. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
    Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
    PubMed     Abstract available


  111. LUSCHER TF
    ST-segment elevation myocardial infarction: the new ESC Guidelines.
    Eur Heart J. 2018;39:75-78.
    PubMed    


  112. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  113. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
    Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
    Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
    PubMed    


  114. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
    Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
    Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  115. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Abstract available


  116. LUSCHER TF
    Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
    Eur Heart J. 2017;38:3109-3113.
    PubMed    


    October 2017
  117. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Abstract available


  118. THYGESEN K, Jaffe AS
    Detecting myocardial infarction type 2: targetting the right patients.
    Eur Heart J. 2017 Oct 5. doi: 10.1093.
    PubMed    


  119. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
    Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
    Eur Heart J. 2017 Oct 3. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  120. LEU HB, Chang HH, Lin SM, Chen YH, et al
    Double trouble for transcatheter aortic valve implantation: a patient with no vascular access and high-risk features for bilateral coronary obstruction.
    Eur Heart J. 2017;38:2787.
    PubMed    


  121. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Abstract available


    August 2017
  122. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available


  123. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available


  124. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed    


  125. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Abstract available


  126. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
    Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Abstract available


  127. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
    Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Abstract available


  128. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
    Discrimination of patients with type 2 myocardial infarction.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    PubMed     Abstract available


  129. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Abstract available


  130. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
    Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
    Eur Heart J. 2017 Aug 7. doi: 10.1093.
    PubMed     Abstract available


    July 2017
  131. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Abstract available


  132. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available


  133. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Abstract available


  134. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
    Infections, atherosclerosis, and coronary heart disease.
    Eur Heart J. 2017 Jul 12. doi: 10.1093.
    PubMed     Abstract available


    May 2017
  135. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Abstract available


    April 2017
  136. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Abstract available


  137. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Abstract available


  138. GABET A, Danchin N, Juilliere Y, Olie V, et al
    Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
    Eur Heart J. 2017;38:1060-1065.
    PubMed     Abstract available


  139. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Abstract available


  140. GEBHARD C
    Women and acute coronary syndromes: still up to no good.
    Eur Heart J. 2017;38:1066-1068.
    PubMed    


  141. ONUMA Y, Serruys PW
    Freedom from long DAPT signals the demise of the bare-metal stent.
    Eur Heart J. 2017;38:970-973.
    PubMed    


  142. CARLSSON M
    The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
    Eur Heart J. 2017;38:999-1001.
    PubMed    


    March 2017
  143. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Abstract available


  144. JIA H, Dai J, Hou J, Xing L, et al
    Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
    Eur Heart J. 2017;38:792-800.
    PubMed     Abstract available


    February 2017
  145. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    PubMed     Abstract available


  146. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
    ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Eur Heart J. 2017;38:586-594.
    PubMed     Abstract available


  147. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
    Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
    Eur Heart J. 2017;38:598-608.
    PubMed     Abstract available


  148. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
    Eur Heart J. 2017 Feb 21. doi: 10.1093.
    PubMed     Abstract available


  149. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
    The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
    Eur Heart J. 2017 Feb 15. doi: 10.1093.
    PubMed    


  150. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
    Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
    Eur Heart J. 2017;38:489-496.
    PubMed     Abstract available


  151. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
    Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
    Eur Heart J. 2017;38:516-523.
    PubMed     Abstract available


  152. MOTWANI M, Dey D, Berman DS, Germano G, et al
    Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
    Eur Heart J. 2017;38:500-507.
    PubMed     Abstract available


  153. PRIES AR, Reglin B
    Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
    Eur Heart J. 2017;38:478-488.
    PubMed     Abstract available


  154. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Abstract available


  155. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
    Increased haematopoietic activity in patients with atherosclerosis.
    Eur Heart J. 2017;38:425-432.
    PubMed     Abstract available


  156. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
    Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
    Eur Heart J. 2017;38:400-412.
    PubMed     Abstract available


  157. LEIPSIC J, Blanke P
    Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
    Eur Heart J. 2017;38:422-424.
    PubMed    


  158. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed    


    December 2016
  159. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
    Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
    PubMed     Abstract available


  160. PELLICANO M, De Bruyne B, Toth GG, Casselman F, et al
    Fractional flow reserve to guide and to assess coronary artery bypass grafting.
    Eur Heart J. 2016 Dec 23. pii: ehw505. doi: 10.1093.
    PubMed     Abstract available


    November 2016
  161. RYAN N, Escaned J
    Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
    Eur Heart J. 2016.
    PubMed    


    October 2016
  162. CREA F, Bairey Merz CN, Beltrame JF, Kaski JC, et al
    The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift.
    Eur Heart J. 2016.
    PubMed    


  163. ALFONSO F, Rivero F
    Coronary revascularization in diabetic patients with chronic kidney disease.
    Eur Heart J. 2016.
    PubMed    


    September 2016
  164. JORGE C, Hiltrop N, Desmet W
    Heart failure with preserved ejection fraction: blame the veins....
    Eur Heart J. 2016.
    PubMed    


  165. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
    Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
    Eur Heart J. 2016.
    PubMed    


    August 2016
  166. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
    Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
    Eur Heart J. 2016.
    PubMed     Abstract available


  167. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
    Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Eur Heart J. 2016.
    PubMed     Abstract available


  168. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
    The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
    Eur Heart J. 2016.
    PubMed     Abstract available


    June 2016
  169. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
    Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
    Eur Heart J. 2016.
    PubMed     Abstract available


    May 2016
  170. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    PubMed    


    April 2016
  171. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
    Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
    Eur Heart J. 2016.
    PubMed     Abstract available


    February 2016
  172. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: